- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00228241
Left Ventricular Function and Remodelling During Permanent Pacing
October 25, 2006 updated by: Aarhus University Hospital Skejby
- Background - Pacemaker treatment gives asynchronous activation of the heart that often results in decreased heart function and clinical heart failure. New pacemaker types that stimulates both left and right ventricle ( biventricular pacemakers ) is introduced to the treatment of patients with heart failure, decreased left ventricular function and ECG signs with left bundle branch block.
- Hypothesis - Ventricular pacing results in remodelling of the left ventricle and decreased left ventricular function. Biventricular pacing do not do this. Ventricular pacing results in heart failure and increased wall stress with decreased 6 minutes walk test and increased BNP in blood samples. This is not seen by biventricular pacing.
- Materials and methods - 3 studies. All patients are examined by echocardiography 2-dimensional, M-mode, 3-dimensional and with tissue harmonic imaging. Study 1) Patients with AV-conduction disorder that needs pacemaker treatment are randomized to DDD-pacemaker or biventricular pacemaker. Study 2) Patients with sick sinus syndrome included in DANPACE are randomized to AAI- or DDD-pacemaker. Study 3 ) Acute study to examine the changes in patients AV-block before DDD-pacemaker implantation and after implantation.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark, 8200
- Andi Eie Albertsen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Sick sinus syndrome
- AV-block
Exclusion Criteria:
- Atrial fibrillation
- AMI
- Heart valve disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
3-dimensional left ventricular ejection fraction
|
Secondary Outcome Measures
Outcome Measure |
---|
NT-proBNP
|
TDI echo parameters
|
6 MHW
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Andi Albertsen, MD, Physician, Skejby University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2003
Study Completion
July 1, 2006
Study Registration Dates
First Submitted
September 26, 2005
First Submitted That Met QC Criteria
September 26, 2005
First Posted (ESTIMATE)
September 28, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
October 26, 2006
Last Update Submitted That Met QC Criteria
October 25, 2006
Last Verified
September 1, 2005
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 130472
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sick Sinus Syndrome
-
Medtronic BRCTerminated
-
Medtronic BRCUnknownBradycardia; Sick Sinus Syndrome, AV BlockGermany, Denmark, Netherlands, Austria, Czech Republic, United Kingdom, Sweden, Finland, Italy, Russian Federation, Switzerland
-
LivaNovaCompletedSinus Node Dysfunction | Brady Tachy SyndromeUnited States, France, Belgium, Germany, United Kingdom, Italy, Monaco, Spain
-
Medtronic BRCVitatron GmbHUnknown
-
China Medical University HospitalUnknownSick Sinus SyndromeTaiwan
-
The DANPACE Investigator GroupTerminatedSick Sinus SyndromeDenmark
-
Abbott Medical DevicesTerminated
-
China National Center for Cardiovascular DiseasesRecruiting
-
Hospital Clinico Universitario de SantiagoSpanish Society of Cardiology; Hospital Universitario Lucus AugustiRecruitingSick Sinus Syndrome | Sinus Node DysfunctionSpain
-
Medtronic Cardiac Rhythm and Heart FailureCompletedSinus Node DysfunctionPeru, Bangladesh, India, Mexico, Argentina, Russian Federation, Uruguay